Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-761
Closed -$45.4K 4396
2017
Q4
$39K Buy
+761
New +$39.6K ﹤0.01% 3800
2017
Q2
Sell
-11,179
Closed -$553K 4600
2017
Q1
$496K Buy
11,179
+9,834
+731% +$423K ﹤0.01% 2270
2016
Q4
$59K Sell
1,345
-2,357
-64% -$100K ﹤0.01% 4130
2016
Q3
$148K Buy
+3,702
New +$157K ﹤0.01% 3342
2014
Q2
Sell
-100
Closed -$4K 4653
2014
Q1
$4K Buy
+100
New +$4.46K ﹤0.01% 4754

Other funds holding CNMD

PEAK6 Group's CNMD Position: Q1 2018 in Review

PEAK6 Group sold out of CONMED (CNMD) in Q1 2018, closing a stake of 761 shares — an estimated $45.4K sold.

PEAK6 Group first reported a position in CNMD in Q1 2014 and held it in 5 quarters. The position peaked at $496K in Q1 2017. 173 funds tracked by Wall St. Rank hold CNMD as of Q1 2018.

  • PEAK6 Group reported no remaining CONMED position as of Q1 2018 after selling out during the quarter.
  • PEAK6 Group sold 761 CONMED shares in Q1 2018, an estimated $45.4K.
  • PEAK6 Group first reported a position in CONMED in Q1 2014 and held it in 5 quarters.
  • PEAK6 Group's CONMED position peaked at $496K in Q1 2017.
  • 173 funds tracked by Wall St. Rank held CONMED as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.